abstract |
The below-described compound has good oral adsorption and exhibits markedly excellent antagonistic action against both NK1 receptors and NK2 receptors. Hydrochloride or fumarate of 1-{2-((2R)-(3,4-dichlorophenyl)-4-(3,4,5-trimethoxybenzoyl)morpholin-2-yl]ethyl}spiro[benzo(c)thiophene-1(3H),4'-piperidin]-(2S)-oxide. |